Join Lachman Consultants at the Fierce Pharma “Fierce JPM Week” in San Francisco, Jan 9 – 10 for two days of insights and engaging discussions exploring the latest in innovation, artificial intelligence, and what is on the mind of some of the top executives in the industry. Lachman will be represented on-site by members of the team, including:
- Frances Zipp, President & CEO
- Keith Lamb, Executive Director, Biologics & BioTech
- Scott Deckebach, Senior Director, Compliance – Data Governance & Integrity
Directly from the Fierce JPM Week website (www.fiercejpmweek.com):
“Connecting Minds, Igniting Change, Navigating the Future of Biopharma and Healthcare.
A pivotal election, new regulations, and an array of technological advancements are poised to usher in a year marked by innovation and change for biopharma and healthcare.
From thought-provoking discussions on the ever-evolving deal dynamics within the industry to unique insights on the regulatory landscape, treatment breakthroughs, and the strategic deployment of AI, some of the greatest minds in pharma and healthcare will convene to explore the most pressing issues and exciting opportunities on the horizon.
Prepare to be enlightened, informed, and inspired as we collectively navigate the future of biopharma and healthcare.”
Our team will be available to meet on-site to discuss your quality-focused opportunities and challenges in the Pharma, Biopharma, Data Integrity, and AI spaces – but time is filling up fast so be sure to reach out to us to schedule your meeting with one of our experts.
Click here to contact us and schedule a time to meet!
